Additional work has shown that EGFR-mediated suppression of SETD2 results in decreased DNA damage repair, resulting in an accumulation of DNA damage in established GBM cells lines, leading to increased mutagenesis and subsequent selective adaptation (172). Here, EGFR is linked to glioblastoma.